[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:nasopharyngeal-carcinoma":3},{"name":4,"total":5,"recruiting":5,"trials":6,"biomarkers":102,"states":103},"Nasopharyngeal Carcinoma",15,[7,15,22,28,34,40,47,53,59,66,72,78,84,90,96],{"nct_id":8,"title":9,"phases":10,"status":12,"updated_at":13,"content_modified":14},"NCT06457503","A Study of Toripalimab in Combination With Cisplatin and Gemcitabine in Participants With Recurrent Metastatic Nasopharyngeal Cancer",[11],"Phase 4","RECRUITING","2026-08-26T02:18:47.742071Z","2026-05-05T02:43:29.355058Z",{"nct_id":16,"title":17,"phases":18,"status":12,"updated_at":20,"content_modified":21},"NCT06592599","Gemcitabine + Docetaxel + Toripalimab Induction in Epstein-Barr Virus (EBV) Associated Nasopharyngeal Carcinoma(NPC)",[19],"Phase 2","2026-08-26T02:15:13.282904Z","2026-05-05T02:43:28.486595Z",{"nct_id":23,"title":24,"phases":25,"status":12,"updated_at":26,"content_modified":27},"NCT06682442","Induction Chemotherapy Response-Guided Radiation for EBV-Associated Nasopharyngeal Carcinoma",[],"2026-08-26T02:15:02.712396Z","2026-05-05T02:43:27.927698Z",{"nct_id":29,"title":30,"phases":31,"status":12,"updated_at":32,"content_modified":33},"NCT06029270","Testing the Addition of BMS-986016 (Relatlimab) to the Usual Immunotherapy After Initial Treatment for Recurrent or Metastatic Nasopharyngeal Cancer",[19],"2026-08-26T02:15:50.539717Z","2026-05-05T02:43:26.906583Z",{"nct_id":35,"title":36,"phases":37,"status":12,"updated_at":38,"content_modified":39},"NCT06064097","A Study Using Nivolumab, in Combination With Chemotherapy Drugs to Treat Nasopharyngeal Carcinoma (NPC)",[19],"2026-08-26T02:17:56.243868Z","2026-05-05T02:43:26.875234Z",{"nct_id":41,"title":42,"phases":43,"status":12,"updated_at":45,"content_modified":46},"NCT06014502","Study to Evaluate IMGS-001 Treatment in Patients With Relapsed or Refractory Advanced Solid Tumors",[44],"Phase 1","2026-08-26T02:16:28.221034Z","2026-07-19T19:36:05.129130Z",{"nct_id":48,"title":49,"phases":50,"status":12,"updated_at":51,"content_modified":52},"NCT04902443","Pomalidomide and Nivolumab in People With Virus-Associated Malignancies With or Without HIV",[44],"2026-08-26T02:17:27.435233Z","2026-06-18T12:24:02.872345Z",{"nct_id":54,"title":55,"phases":56,"status":12,"updated_at":57,"content_modified":58},"NCT05983432","Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors",[44],"2026-08-26T02:16:56.877406Z","2026-05-05T02:43:28.678419Z",{"nct_id":60,"title":61,"phases":62,"status":12,"updated_at":64,"content_modified":65},"NCT05038150","Study of SGN1 in Patients With Advanced Solid Tumor",[63],"Phase 1\u002FPhase 2","2026-08-26T02:18:36.226508Z","2026-05-05T02:35:31.902772Z",{"nct_id":67,"title":68,"phases":69,"status":12,"updated_at":70,"content_modified":71},"NCT05733091","Assessment of Functional and Symptom Outcomes for Survivors of Paranasal Sinus, Nasopharyngeal and Skull Base Tumors",[],"2026-08-26T02:18:58.141497Z","2026-05-13T02:55:06.373595Z",{"nct_id":73,"title":74,"phases":75,"status":12,"updated_at":76,"content_modified":77},"NCT05207098","A Study of Neurocognitive Tests and Questionnaires for People With Head and Neck Cancer Who Are Undergoing Radiation Therapy",[],"2026-08-26T02:17:30.961790Z","2026-06-06T00:48:49.527149Z",{"nct_id":79,"title":80,"phases":81,"status":12,"updated_at":82,"content_modified":83},"NCT07124000","DESTINY-PANTUMOUR04",[],"2026-08-26T02:15:24.145250Z","2026-05-13T02:55:06.658082Z",{"nct_id":85,"title":86,"phases":87,"status":12,"updated_at":88,"content_modified":89},"NCT03010150","Blood Tests and Questionnaires in Studying Adherence to Preventative Swallowing Exercises in Participants With Metastatic Head and Neck Cancer",[],"2026-08-26T02:16:32.589113Z","2026-05-13T02:55:06.106681Z",{"nct_id":91,"title":92,"phases":93,"status":12,"updated_at":94,"content_modified":95},"NCT02012699","Integrated Cancer Repository for Cancer Research",[],"2026-08-26T02:16:35.654046Z","2026-05-13T02:55:06.082833Z",{"nct_id":97,"title":98,"phases":99,"status":12,"updated_at":100,"content_modified":101},"NCT00900419","Biomarkers in Patients With Respiratory Tract Dysplasia or Lung Cancer, Head and Neck Cancer, or Aerodigestive Tract Cancer and in Normal Volunteers",[],"2026-08-26T02:18:49.989941Z","2026-05-13T02:55:06.067169Z",[],[104,108,112,115,119,122,125,128,132,135,138,141,144,148,151,154,157,160,163,166,169,172,175],{"state":105,"count":106,"slug":107},"California",9,"california",{"state":109,"count":110,"slug":111},"Ohio",6,"ohio",{"state":113,"count":110,"slug":114},"Texas","texas",{"state":116,"count":117,"slug":118},"Colorado",5,"colorado",{"state":120,"count":117,"slug":121},"Florida","florida",{"state":123,"count":117,"slug":124},"Illinois","illinois",{"state":126,"count":117,"slug":127},"New York","new-york",{"state":129,"count":130,"slug":131},"Arizona",4,"arizona",{"state":133,"count":130,"slug":134},"Massachusetts","massachusetts",{"state":136,"count":130,"slug":137},"Missouri","missouri",{"state":139,"count":130,"slug":140},"Pennsylvania","pennsylvania",{"state":142,"count":130,"slug":143},"Wisconsin","wisconsin",{"state":145,"count":146,"slug":147},"Connecticut",3,"connecticut",{"state":149,"count":146,"slug":150},"Georgia","georgia",{"state":152,"count":146,"slug":153},"Iowa","iowa",{"state":155,"count":146,"slug":156},"Kentucky","kentucky",{"state":158,"count":146,"slug":159},"Maryland","maryland",{"state":161,"count":146,"slug":162},"Michigan","michigan",{"state":164,"count":146,"slug":165},"Nebraska","nebraska",{"state":167,"count":146,"slug":168},"North Carolina","north-carolina",{"state":170,"count":146,"slug":171},"South Carolina","south-carolina",{"state":173,"count":146,"slug":174},"Tennessee","tennessee",{"state":176,"count":146,"slug":177},"Washington","washington"]